Delivery Order SPE2DR25D1041-SPE2DR26FHR1M
Award Date 1/13/26
Potential Completion Date 1/14/26
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5,762.79 to AmerisourceBergen Drug Corp for the supply of Exforge 10-320 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on December 19, 2025, with an ultimate completion date of December 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,145.66 to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical procurement. The place of performance is listed as Conshohocken, Pennsylvania, which coincides with AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,679.83 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Exforge 5-320 mg tablets (30-count). This firm fixed-price contract, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate headquarters in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,518.05 to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Exforge 5-160 mg tablets (30-count). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a $3,768.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Exforge 10-320 mg on July 14, 2025, with completion expected by July 15, 2025. This non-set-aside award represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,986.63 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Exforge 5-160 mg tablets (30-count). The contract utilizes firm fixed pricing with a completion date of January 6, 2026, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and fulfills this...
- The Defense Logistics Agency awarded a $2,699.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Exforge 5-320 mg tablets (30-count). This non-set-aside, competitively awarded delivery order is scheduled for completion by November 3, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Exforge 10-320 mg tablets (30-count packaging) with a ceiling value of $8,065.53 under firm fixed pricing. This non-set-aside, competitively awarded delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $16,573.67 to AmerisourceBergen Drug Corp for the supply of Exforge 10-320 mg tablets (30-count) with a firm fixed-price structure. The award, issued on January 9, 2026, with an ultimate completion date of January 12, 2026, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,525.28 to AmerisourceBergen Drug Corp on May 28, 2025, for the supply of Exforge 5-160 mg tablets (30-count unit). This firm fixed-price contract, with a completion date of May 29, 2025, represents a routine pharmaceutical procurement executed through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from...